|
Delayed
NYSE
17:09:14 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1751 USD | -1.07% |
|
+6.06% | -70.12% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.07% | +6.06% | -10.89% | -73.07% | -70.12% | -90.97% | -97.20% | -99.76% | -99.79% | 2.6M | |
| +0.06% | +7.20% | +3.13% | +57.21% | +85.29% | +54.04% | +111.13% | +9.49% | - | 74.27B | |
| -2.29% | -1.51% | -3.29% | +2.80% | +16.60% | +33.30% | +75.15% | +209.56% | +5,416.83% | 61.21B | |
| +0.28% | +7.27% | +3.53% | +71.76% | +67.94% | +31.74% | +23.80% | -56.54% | - | 27.55B | |
| -1.86% | -2.98% | -4.07% | +16.43% | -31.67% | -18.19% | +361.33% | +331.22% | +705.76% | 26.38B | |
| -1.17% | +3.98% | -11.68% | +9.95% | +4.66% | +1.39% | -3.37% | -71.77% | - | 25.34B | |
| +0.57% | +3.66% | +8.52% | +34.15% | +13.07% | +25.59% | -9.08% | -18.92% | +100.52% | 20.84B | |
| -1.47% | +4.46% | -10.22% | +23.09% | +23.15% | -8.09% | +513.33% | - | - | 14.94B | |
| +1.29% | -2.49% | -16.07% | +19.03% | +177.32% | +163.31% | +333.06% | +1,388.09% | +653.35% | 15.17B | |
| -2.75% | -0.09% | +4.00% | +10.50% | +29.43% | +42.50% | +159.87% | +176.73% | +280.99% | 14.41B | |
| -4.79% | -5.61% | +28.28% | +14.60% | -6.63% | -14.73% | +750.52% | +203.53% | +87.06% | 13.66B | |
| -2.42% | -4.20% | -1.00% | -1.28% | -12.96% | +14.33% | +235.79% | +496.57% | +4,250.60% | 11.99B | |
| +1.67% | +2.36% | +8.03% | +17.54% | -13.72% | -25.57% | +160.00% | +133.25% | - | 11.26B | |
| -6.99% | +1.67% | -22.88% | -16.28% | +0.75% | +105.82% | +150.81% | +3.38% | +826.45% | 10.15B | |
| -3.53% | -6.24% | -15.61% | -18.69% | +2.39% | +34.01% | +117.01% | +93.57% | +642.69% | 9.4B | |
| -6.51% | +9.92% | +14.71% | +18.78% | +339.14% | +235.71% | +440.06% | -18.81% | - | 9.85B | |
| -6.59% | -5.93% | -10.64% | +6.40% | +19.82% | +66.77% | +8.74% | +111.17% | - | 8.78B | |
| -0.69% | +4.44% | -0.13% | +18.05% | +9.44% | -24.23% | +94.81% | -23.20% | - | 8.71B | |
| -5.82% | -4.57% | -18.42% | -10.36% | +165.57% | +443.07% | +648.07% | -55.21% | -46.38% | 8.11B | |
| -4.34% | -0.44% | +6.04% | +16.11% | +5.32% | +137.11% | +438.74% | - | - | 7.06B | |
| Average | -2.37% | +3.02% | -2.43% | +10.84% | +41.24% | +60.35% | +225.63% | +156.24% | +1,165.28% | 18.95B | |
| Weighted average by Cap. | -1.65% | +2.76% | -1.07% | +23.87% | +44.43% | +48.32% | +181.73% | +149.55% | +2,260.33% |
- Stock Market
- Stocks
- MTNB Stock
- Sector Matinas BioPharma
Select your edition
All financial news and data tailored to specific country editions
